S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Caracal Expands Healthcare PPE Portfolio with PRIMED Partnership

Detroit-based Caracal Products & Services is rolling out a new suite of protective gowns and medical masks, aiming to bolster supply chains for frontline healthcare workers. By teaming up with PRIMED Medical Products, the company is diversifying its clinical gear to cover protection levels ranging from standard isolation to high-risk trauma care.

Caracal Expands Healthcare PPE Portfolio with PRIMED Partnership
Photo: Bio & News

The expansion introduces two specialized gowns designed for varied clinical demands. The Overhead Film Gown utilizes a lightweight polyethylene layer for fluid protection, while the AAMI Level 2 Isolation Gown employs breathable SMS material for increased durability. Both designs prioritize practitioner comfort through ergonomic thumb loops and overhead neck closures, with the Level 2 variant adding elastic cuffs for secure placement.

Beyond gowns, the new mask lineup targets distinct risk profiles. Two variants meet ASTM Level 2 standards, suitable for dental procedures, wound care, or routine line changes. For high-stakes environments like emergency rooms and intensive care units, the company has added an ASTM Level 3 mask designed to withstand heavy splash and spray exposure. This partnership with North American supplier PRIMED serves to stabilize distribution channels, ensuring that medical facilities maintain consistent access to critical protective equipment.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!